Certuity’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Certuity’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$231K	–	373
2023 Q3	$231K	Sell	2,000 -45	-2%	-$4.83K	0.03%	229
2023 Q2	$210K	Buy	+2,045	New	+$216K	0.02%	243

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Certuity's HZNP Position: Q4 2023 in Review

Certuity sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,000 shares — an estimated $231K sold.

Certuity first reported a position in HZNP in Q2 2023 and held it in 2 quarters. The position peaked at $231K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Certuity reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Certuity sold 2,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $231K.
Certuity first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2023 and held it in 2 quarters.
Certuity's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $231K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Certuity's 13F filing for Q4 2023, filed 5 Feb 2024.